GLP-1 drugs, once primarily used for diabetes treatment, have demonstrated impressive effectiveness in treating obesity, which affects over 100 million Americans, according to PBS NewsHour reporting. The class of medications is generating significant clinical interest as researchers explore both the therapeutic benefits and potential risks associated with their use. Medical experts including Dr.
Jody Dushay, Dr. Rekha B. Kumar, Dr.
Anna Lembke, and Dr. Ziyad Al-Aly discussed the promise of these drugs alongside concerns about safety and long-term outcomes in recent coverage.